Home Tags Pharmaceuticals
A depression drug that’s been called ‘the most important discovery in half a century’ just got a big step closer to FDA approval
Esketamine, a first-of-its-kind depression drug made by Johnson & Johnson, got a big nod on Tuesday from a group of experts convened by regulators.
Meet the Sacklers, one of the richest families in America, who built their $14 billion fortune off of controversial prescription drug OxyContin
The secretive family's $14 billion fortune comes mainly from sales of the prescription painkiller. They're also well-known for their philanthropic endeavors.
Walmart and CVS just resolved their $4 billion dispute over where you can pick up your prescriptions
People whose prescriptions are handled by CVS Caremark will still be able to pick them up at Walmart pharmacies, after the companies ended a pricing spat.
Vistin Pharma, known for its type-2 diabetes drug Metformin, said in March that it would try its hand at the energy market. Things didn't go to plan.
Trump may have shamed Pfizer for increasing drug prices, but that isn’t stopping drugmakers from doing more of the same
Pharmaceutical companies are increasing drug price again this month, and they could be even larger than usual.
A smiley-face text message about hiking the price of an old drug is at the center of a massive lawsuit being brought against nearly 20 big drug compan...
The allegation is part of a larger civil antitrust complaint being brought by most US states regarding price hikes on a number of generic drugs.
Two huge drugmakers are spinning off iconic brands like Advil, ChapStick and Emergen-C with nearly $13 billion in sales — and it’s part of...
The products involved in the deal are familiar pharmacy names, but they also have lower margins than other medicines.
A treatment for the most common food allergy could be available next year, and one biotech just drew ahead in the race for the $3 billion market
Kids with peanut allergies haven't had many options, but first-of-their-kind treatments could change that as soon as 2019.
GlaxoSmithKline will be broken up in a megadeal with Pfizer that could change the face of global healthcare
The joint venture could have combined sales of nearly $10 billion.
AbbVie just stopped enrolling patients in a late-stage trial of a high-profile lung cancer drug after patients had shorter survival results on the drug.